Matrix Products for Pressure Ulcers
(RESTORE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
A multicenter prospective modified platform trial evaluating several cellular, acellular, and matrix like products and standard of care versus matched standard of care controls in the management of nonhealing pressure ulcers.
Who Is on the Research Team?
Thomas Serena, MD
Principal Investigator
Serena Group
Are You a Good Fit for This Trial?
This trial is for people with chronic, nonhealing pressure ulcers (bed sores) or similar skin wounds. Participants must have these types of hard-to-heal sores and meet basic health requirements set by the study team.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares several new wound healing products—Activate Matrix, AmnioDefend FT Matrix, Palisade DM Matrix, Sentry SL Matrix, Shelter DM Matrix—each used along with standard care, against standard care alone to see which helps heal stubborn pressure ulcers best.
How Is the Trial Designed?
5
Treatment groups
Experimental Treatment
Two layers: amnion and chorion
One layer: amnion
Two layers: amnion and chorion
Three layers: amnion, intermediate layer, and chorion
Three layers: amnion, intermediate layer, and chorion
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sequence LifeScience, Inc.
Lead Sponsor
Serena Group
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.